Back to announcement
20251030_LABS_Laporan Informasi dan Fakta Material_31980959.pdf
Financial statement Text extracted LABSSource file signed link, expires in 15 minutes
Extracted text 4
Page 1
Go To English Page
Nomor Surat 01.060/SP/MM/UBC/X/25
Nama Perusahaan PT UBC Medical Indonesia Tbk
Kode Emiten LABS
Lampiran 4
Penyampaian Laporan Keuangan
Perihal
Tahun Fiskal : 2025
Tahun Buku : SEP
Jenis Periode : Kuartal III / Third Quarter
Dengan ini kami untuk dan atas nama perusahaan menyampaikan laporan keuangan, sebagai berikut:
Nama Emiten : PT UBC Medical Indonesia Tbk
Bidang Usaha : Distributor Alat Kesehatan
Nilai Ekuitas : 150.718.003.566
Nilai Pendapatan Periode Sebelumnya : 106.429.260.405
Nilai Pendapatan : 135.436.065.715
Selisih dengan Nilai Pendapatan 29.006.805.310
:
Periode Sebelumnya
Kurs : Rupiah / IDR
Rate : 16.680
Jenis Laporan atas Laporan Keuangan : Tidak Diaudit / Unaudit
Opini Audit : -
Demikian untuk diketahui.
Hormat Kami,
PT UBC Medical Indonesia Tbk
Franciscus Xaverius Yoshua Raintjung
Direktur Utama
PT UBC Medical Indonesia Tbk
Kawasan Industri Pulogadung, Jl. Rawa Gelam V, Blok L, No Kav 11-13, Kel.
Telepon : 021-38865110, Fax : , www.ubcindonesia.com
Nama Pengirim Franciscus Xaverius Yoshua Raintjung
Jabatan Direktur Utama
Page 2
Tanggal dan Waktu 30-10-2025 19:18
Lampiran 1. FinancialStatement-2025-III-LABS.pdf
2. SPD UBC Q3 FY25 - Consolidated (1).pdf
3. PT UBC Medical Indonesia - Q3 2025 (2).pdf
4. 01_060_LABS_Surat Pengantar LK Q3.pdf
Dokumen ini merupakan dokumen resmi PT UBC Medical Indonesia Tbk yang tidak memerlukan tanda tangan
karena dihasilkan secara elektronik oleh sistem pelaporan elektronik. PT UBC Medical Indonesia Tbk bertanggung
jawab penuh atas informasi yang tertera didalam dokumen ini.
Page 3
Go To Indonesian Page
Letter / Announcement No. 01.060/SP/MM/UBC/X/25
Issuer Name PT UBC Medical Indonesia Tbk
Issuer Code LABS
Attachment 4
Subject Submission of Financial Report
Fiscal Year : 2025
End of Year : SEP
Period Type : Kuartal III / Third Quarter
The company hereby announce the Submission of Financial Report as follows:
Issuer Name : PT UBC Medical Indonesia Tbk
Business Fields : Distributor Alat Kesehatan
Equity Value : 150.718.003.566
Previous Period Revenue : 106.429.260.405
Revenue : 135.436.065.715
Difference with Previous Period 29.006.805.310
:
Revenue
Currency : Rupiah / IDR
Rate : 16.680
Types of Reports on Financial : Tidak Diaudit / Unaudit
Type of Auditor's Opinion : -
Thus to be informed accordingly.
Respectfully,
PT UBC Medical Indonesia Tbk
Franciscus Xaverius Yoshua Raintjung
Direktur Utama
PT UBC Medical Indonesia Tbk
Kawasan Industri Pulogadung, Jl. Rawa Gelam V, Blok L, No Kav 11-13, Kel.
Phone : 021-38865110, Fax : , www.ubcindonesia.com
Sender Name Franciscus Xaverius Yoshua Raintjung
Function Direktur Utama
Page 4
Date and Time 30-10-2025 19:18
Attachment 1. FinancialStatement-2025-III-LABS.pdf
2. SPD UBC Q3 FY25 - Consolidated (1).pdf
3. PT UBC Medical Indonesia - Q3 2025 (2).pdf
4. 01_060_LABS_Surat Pengantar LK Q3.pdf
This is an official document of PT UBC Medical Indonesia Tbk that does not require a signature as it was generated
electronically by the electronic reporting system. PT UBC Medical Indonesia Tbk is fully responsible for the
information contained within this document.
Names mentioned 3 people and organisations named in the text · linked when the evidence is strong
unresolved
person
Franciscus Xaverius Yoshua Raintjung
· Direktur Utama
p.1 ×6
unresolved
person
Function
· Direktur Utama
p.3
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.